Eli Lilly is expecting CMS to reverse course on its Medicare coverage policies around new Alzheimer's drugs as more evidence shows they are capable of reducing amyloid plaques in the brain, Reuters exclusively reported April 21.
Payer
Aetna's Medicaid program in Maryland is piloting a new program for covered doula services in collaboration with digital health solution provider, Mae.
The National Community Pharmacists Association is skeptical new reimbursement policies from Express Scripts will amount to meaningful change for independent pharmacies.
HumanaChoice received an estimated $27.3 million in overpayments in 2015 and 2016, according to an audit from HHS' Office of Inspector General.
UnitedHealth Group CEO Andrew Witty was paid $20.9 million in total compensation in 2022, according to regulatory filings published April 21.
Drug manufacturers are lobbying for Medicare to cover the cost of expensive new drugs meant for treating obesity, The Wall Street Journal reported April 24.
Molina Healthcare CEO Joseph Zubretsky received the largest compensation package among the most prominent payer CEOs in 2022, according to regulatory filings published with the Securities and Exchange Commission.
Hundreds of physicians across the nation have taken to Twitter to share their thoughts on a simple question: What is the insurance denial in your specialty that frustrates you and your patients the most?
House Republicans have included Medicaid work requirement proposals in their bill to raise the debt ceiling into next year, The Washington Post reported April 20.
Hospitals across New Hampshire say Anthem's operations and overall performance in the state has left providers with $300 million in unprocessed claims and created "universal dissatisfaction" with the Elevance Health subsidiary.
